Ferté suggested that combined intratumoral and peritumoral radiomics was a promising way to predict CD8 cell infiltration and to infer clinical outcomes for cancer patients who had been treated with anti-PD-1 and PD-L1 (32). The gene discussed is CD8A; the disease is cancer.